Maxell, Ltd. (TYO:6810)

Acelyrin Revenue

Maxell had revenue of 30.27B JPY in the quarter ending June 30, 2025, a decrease of -3.55%. This brings the company's revenue in the last twelve months to 128.69B, up 0.31% year-over-year. In the fiscal year ending March 31, 2025, Maxell had annual revenue of 129.81B with 0.52% growth.

• Revenue (ttm): 128.69B
• Revenue Growth: +0.31%
• P/S Ratio: 0.66
• Revenue / Employee: 33.89M
• Employees: 3,797
• Market Cap: 85.00B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	129.81B	667.00M	0.52%
Mar 31, 2024	129.14B	-3.64B	-2.74%
Mar 31, 2023	132.78B	-5.44B	-3.94%
Mar 31, 2022	138.22B	-840.00M	-0.60%
Mar 31, 2021	139.06B	-5.99B	-4.13%